ContraFect

-$0.09 (-3.12%) Today
-$0.01 (-0.36%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ContraFect and other ETFs, options, and stocks.

About CFRX

ContraFect Corp. is a clinical stage biotechnology company, which engages in discovering and developing direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins and Amurin Peptides.

CEO
Roger J. Pomerantz
Employees
38
Headquarters
Yonkers, New York
Founded
2008

CFRX Key Statistics

Market cap
109.74M
Price-Earnings ratio
—
Dividend yield
—
Average volume
176.05K
High today
$3.06
Low today
$2.77
Open price
$2.90
Volume
164.31K
52 Week high
$4.54
52 Week low
$2.11

CFRX Earnings

-$0.51
-$0.34
-$0.17
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure